Cargando…
Bilateral Femoral Insufficiency Fractures Likely Related to Long-Term Alendronate Therapy
Osteoporosis-related fractures are a major public health problem and one in two women and one in four men are affected with osteoporosis-related fractures. Alendronate (Fosamax) is one of the first bisphosphonates used to treat osteoporosis effectively. Recently, however, there is a concern regardin...
Autores principales: | Gudena, Ravindra, Werle, Jason, Johnston, Kelly |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135260/ https://www.ncbi.nlm.nih.gov/pubmed/21776372 http://dx.doi.org/10.4061/2011/810697 |
Ejemplares similares
-
Simultaneous Bilateral Insufficiency Femoral Fractures After Long-Term Alendronate Treatment: A Lesson Not Yet Learned
por: Rigkos, Dimitrios, et al.
Publicado: (2023) -
Discontinuation of alendronate and administration of bone-forming agents after surgical nailing may promote union of atypical femoral fractures in patients on long-term alendronate therapy
por: Lin, Tsung-Li, et al.
Publicado: (2013) -
Acetabular and sacral insufficiency fractures in a patient with a long-term history of Alendronate consumption; a case report
por: Gharanizadeh, Kaveh, et al.
Publicado: (2023) -
Bilateral atypical insufficiency fractures of the proximal tibia and a unilateral distal femoral fracture associated with long-term intravenous bisphosphonate therapy: a case report
por: Imbuldeniya, Arjuna Mahinda, et al.
Publicado: (2012) -
Bilateral Femoral Neck Insufficiency Fractures after Use of a Long-term Anti-resorptive Drug Therapy for Osteoporosis: A Case Report
por: Ahn, Dong-Ki, et al.
Publicado: (2015)